Indonesian Food and Drug Authority
Indonesian Food and Drug Authority (BPOM) is a government agency in Indonesia responsible for regulating and supervising the safety, quality, and distribution of food, drugs, cosmetics, and other health-related products. Established to ensure public health and safety, BPOM plays a crucial role in the Indonesian healthcare system by enforcing standards and regulations related to the production and consumption of food and drug products.
History[edit]
The Indonesian Food and Drug Authority was established in response to the growing need for a regulatory body to oversee the safety and quality of food and drug products in Indonesia. Over the years, BPOM has evolved to adapt to the changing landscape of health and safety regulations, incorporating the latest scientific and technological advancements in its operations.
Functions[edit]
BPOM's primary functions include:
- Evaluating and approving new food products and medicines before they are marketed.
- Monitoring the safety and efficacy of products post-market.
- Conducting risk assessments and safety evaluations of food and drug products.
- Implementing regulations and standards for the production, distribution, and sale of food and drug products.
- Conducting inspections and audits of manufacturing facilities to ensure compliance with health and safety standards.
- Taking enforcement actions against products and manufacturers that violate regulations.
Organizational Structure[edit]
The Indonesian Food and Drug Authority is structured to efficiently manage its wide range of responsibilities. It comprises several directorates, each focusing on specific areas such as food evaluation and monitoring, drug evaluation and monitoring, traditional medicines and supplements, and inspection and enforcement.
Challenges and Controversies[edit]
Like many regulatory bodies, BPOM faces challenges in its efforts to protect public health. These include dealing with counterfeit and substandard products, ensuring the safety of imported goods, and adapting to new health threats. Controversies occasionally arise over its decisions, particularly concerning product approvals and bans, reflecting the complex balance between public health, industry interests, and consumer rights.
Impact[edit]
BPOM's work has a significant impact on public health in Indonesia. By ensuring that food and drug products meet safety and quality standards, BPOM helps to prevent health hazards and protect consumers from harmful products. Its regulatory actions also support the development of the Indonesian food and drug industries by promoting good manufacturing practices and innovation.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian